BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma
Sign Up to like & getrecommendations! Published in 2017 at "Cancer Medicine"
DOI: 10.1002/cam4.982
Abstract: Nasopharyngeal carcinoma (NPC) can develop cisplatin‐resistant phenotype. Research has revealed that enriched in cancer stem cell population is involved in developing cisplatin‐resistant phenotype. CD271 is a candidate stem cell maker in head and neck cancers.… read more here.
Keywords: cisplatin resistant; cisplatin; expression; bex3 ... See more keywords